Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2020 | Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury: A systematic review and meta-analysis | Chen C.-T.; LING-YIN CHANG ; Chuang C.-W.; Wang S.-C.; Kao M.-C.; Tzeng I.-S.; Kuo K.-L.; Wu C.-C.; Tsai P.-S.; Huang C.-J. | Toxicology Letters | 5 | 4 | |
2016 | Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis | Lin K.-H.; Ho Y.-H.; Chiang J.-C.; Li M.-W.; Lin S.-H.; Chen W.-M.; Chiang C.-L.; Lin Y.-N.; Yang Y.-J.; CHIUNG-NIEN CHEN ; Lu J.; Huang C.-J.; Tigyi G.; Yao C.-L.; H. Lee | Scientific Reports | 23 | 25 | |
2007 | Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells | Chu S.-T.; Cheng H.-H.; Huang C.-J.; HONG-CHIANG CHANG ; Chi C.-C.; Su H.-H.; Hsu S.-S.; Wang J.-L.; Chen I.-S.; Liu S.-I.; Lu Y.-C.; Huang J.-K.; Ho C.-M.; Jan C.-R. | Life Sciences | 66 | 56 | |
2008 | Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma | Chung C.-J.; Huang C.-J.; YEONG-SHIAU PU ; Su C.-T.; Huang Y.-K.; Chen Y.-T.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 24 | 20 | |
2018 | Postprandial Metabolomics Response to Various Cooking Oils in Humans | Wang P.-S.; CHING-HUA KUO ; Yang H.-C.; Liang Y.-J.; Huang C.-J.; Sheen L.-Y. ; Pan W.-H. | Journal of Agricultural and Food Chemistry | 6 | 7 | |
2016 | Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma | Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; CHUN-JEN LIU ; PEI-JER CHEN ; Lin S.-M.; MING-WHEI YU | Hepatology | 14 | 13 | |
2019 | Rare Concurrence of Two Congenital Disorders: Miller-Dieker Syndrome and T-Cell Lymphopenia | Chee S.-Y.; Guo J.-W.; Huang C.-J.; YIN-HSIU CHIEN ; Lee Y.-C.; Feng W.-K. | Cytogenetic and Genome Research | 0 | 0 | |
2021 | Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature | Huang C.-S.; TZU-PIN LU ; Liu C.-Y.; Huang C.-J.; Chiu J.-H.; Chen Y.-J.; Tseng L.-M.; Huang C.-C. | Breast Cancer Research and Treatment | 4 | 4 | |
1996 | The role of video-assisted thoracic surgery in the diagnosis and treatment of indeterminate pulmonary lesion | JANG-MING LEE ; Lee Y.-C.; Huang C.-J.; Luh S.-P.; Lee C.-J. | International Surgery | 2 | 0 | |
2017 | Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome | Ma I.-H.; Chen L.; Tu W.-H.; Lu C.-J.; Huang C.-J.; WEI-LI CHEN | Taiwan Journal of Ophthalmology | 14 | 0 | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy | CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG | Journal of Clinical Oncology | 240 | 224 | |
2021 | Targeted sequencing of taiwanese breast cancer with risk stratification by the concurrent genes signature: A feasibility study | Huang C.-S.; Liu C.-Y.; TZU-PIN LU ; Huang C.-J.; Chiu J.-H.; Tseng L.-M.; Huang C.-C. | Journal of Personalized Medicine | 2 | 2 | |
2008 | Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area | Chung C.-J.; Huang C.-J.; YEONG-SHIAU PU ; Su C.-T.; Huang Y.-K.; Chen Y.-T.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 70 | 61 | |
2013 | A vortex method suitable for long time simulations of flow over body of arbitrary geometry | Huang C.-J.; Huang M.-J. | Computers and Fluids | 4 | 3 | |
2014 | Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses | KUAN-HUNG LU ; Tseng H.-C.; Liu C.-T.; Huang C.-J.; Chyuan J.-H.; Sheen L.-Y. | Food and Function | 43 | 39 |